Cvbt.com develops biopharmaceuticals to treat cardiovascular disease.
Title
CardioVascular BioTherapeutics, Inc.
Description
Excerpted from the website description:
- Cardio Vascular Bio Therapeutics - CVBT is a biopharmaceutical company established to commercialize the breakthrough therapy developed by Dr. Thomas-Joseph Stegmann to treat coronary artery disease with a process known as angiogenesis. The treatment consists of injecting human growth factor near a blocked coronary artery which in turn, improves blood flow into the ischemic heart.
Languages
English
Address
- 1635 Village Center Circle, #250
- Las Vegas NV 89144 US
Contact
- Cardio Vascular Genetic Engineering
-
- +1 714 779 5033 x702, Fax: +1 571 434 4620
Additional Information
Related Domains
External Links
- Alexa: Cvbt.com
- WHOIS for Cvbt.com
Categories:
- Adjunct Bypass Surgery
- Angina Cure
- Angiogenesis
- Atherosclerosis
- Biopharmaceutical
- Biotech
- Biotechnology
- Blood Vessel Blockage
- Cardiology
- Coronary Artery Disease
- Coronary Heart Disease
- Cure Coronary Heart Disease
- Daniel Montano
- Diabetes
- Diabetic Vascular Disease
- Disease Treatment
- Emerging Biotech Growth Company
- FGF
- Fibroblast Growth Factor
- Gene Therapy
- Grow Blood Vessels
- Heart Disease
- Human Growth Factors
- Ischemia
- Medical Applications
- Medical Research
- Mellitus
- Myocardial Revascularization
- Neoangiogenesis
- Nerve Regeneration
- New Vessel Growth
- No Option Heart Patient
- Peripheral Artery Disease
- Peripheral Vascular Disease
- Protein Drug
- Protein Drug Candidate
- Protein Drug Therapy
- Protein Growth Factor
- Regenerate Tissue
- Regenerative Medicine
- Stroke
- Thomas Stegmann
- Vascular Disease
- Wound Healing